Morgan Stanley’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
1,150,121
+404,644
| +54% | +$1.38M | ﹤0.01% | 4256 |
|
|
2025
Q1 | $2.99M | Sell |
745,477
-343,984
| -32% | -$1.38M | ﹤0.01% | 4324 |
|
|
2024
Q4 | $7.07M | Buy |
1,089,461
+22,403
| +2% | +$145K | ﹤0.01% | 3689 |
|
|
2024
Q3 | $5.91M | Buy |
1,067,058
+172,694
| +19% | +$957K | ﹤0.01% | 3842 |
|
|
2024
Q2 | $4.99M | Buy |
894,364
+50,843
| +6% | +$284K | ﹤0.01% | 3876 |
|
|
2024
Q1 | $5.66M | Sell |
843,521
-828,791
| -50% | -$5.56M | ﹤0.01% | 3821 |
|
|
2023
Q4 | $15.3M | Buy |
1,672,312
+1,058,019
| +172% | +$9.65M | ﹤0.01% | 3582 |
|
|
2023
Q3 | $3.39M | Buy |
614,293
+43,997
| +8% | +$243K | ﹤0.01% | 4014 |
|
|
2023
Q2 | $4.87M | Buy |
570,296
+53,332
| +10% | +$455K | ﹤0.01% | 3793 |
|
|
2023
Q1 | $4.75M | Buy |
516,964
+327,379
| +173% | +$3.01M | ﹤0.01% | 3828 |
|
|
2022
Q4 | $1.94M | Sell |
189,585
-25,457
| -12% | -$260K | ﹤0.01% | 4492 |
|
|
2022
Q3 | $3.17M | Buy |
215,042
+18,399
| +9% | +$271K | ﹤0.01% | 4062 |
|
|
2022
Q2 | $2.11M | Buy |
196,643
+78,756
| +67% | +$845K | ﹤0.01% | 4495 |
|
|
2022
Q1 | $1.27M | Buy |
117,887
+112,808
| +2,221% | +$1.22M | ﹤0.01% | 4831 |
|
|
2021
Q4 | $82K | Sell |
5,079
-35,836
| -88% | -$579K | ﹤0.01% | 6551 |
|
|
2021
Q3 | $875K | Buy |
+40,915
| New | +$875K | ﹤0.01% | 5134 |
|